# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-23-022253
Filing Date
2023-06-23
Accepted
2023-06-23 16:19:56
Documents
17
Period of Report
2023-06-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form8-k.htm iXBRL | 8-K | 36987
2 |  | form8-k_001.jpg | GRAPHIC | 5681
3 |  | ex99-1.htm | EX-99.1 | 1996
4 |  | ex99-1_001.jpg | GRAPHIC | 655341
5 |  | ex99-2.htm | EX-99.2 | 1465
6 |  | ex99-2_001.jpg | GRAPHIC | 681051
| Complete submission text file | 0001493152-23-022253.txt |  | 2070845

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | lpcn-20230623.xsd | EX-101.SCH | 3015
8 | XBRL LABEL FILE | lpcn-20230623_lab.xml | EX-101.LAB | 34240
9 | XBRL PRESENTATION FILE | lpcn-20230623_pre.xml | EX-101.PRE | 22359
11 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 3317

Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 231037953
SIC: 2834 Pharmaceutical Preparations